BIVIGAM®
Primary Humoral Immunodeficiency (PI)
ApprovedCommercial
Key Facts
About ADMA Biologics
ADMA Biologics is an end-to-end commercial biopharmaceutical company leading a new age of plasma-derived specialty biologics, with a focus on improving the lives of immune compromised patients and those at risk for certain infections. The company has built a vertically integrated model encompassing plasma collection, proprietary manufacturing, and commercialization of FDA-approved immune globulin products. ADMA's strategic direction emphasizes achieving plasma self-sufficiency, expanding its product portfolio, and leveraging its patented immunotechnology platform for future growth.
View full company profileTherapeutic Areas
Other Primary Humoral Immunodeficiency (PI) Drugs
| Drug | Company | Phase |
|---|---|---|
| ASCENIV™ | ADMA Biologics | Approved |